Rabeximod

CAS No. 872178-65-9

Rabeximod( —— )

Catalog No. M34686 CAS No. 872178-65-9

Rabeximod is a potent immunomodulator that reduces the severity of autoimmune diseases in rat models.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 392 Get Quote
5MG 610 Get Quote
10MG 867 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Rabeximod
  • Note
    Research use only, not for human use.
  • Brief Description
    Rabeximod is a potent immunomodulator that reduces the severity of autoimmune diseases in rat models.
  • Description
    Rabeximod is a potent immunomodulator that reduces the severity of autoimmune diseases in rat models. Rabeximod inhibits arthritis in a time-dependent manner by stimulating TLR2 and TLR4 downstream to block the activation of inflammatory cells, most likely macrophages. Rabeximod effectively reduces brain antigen presentation in mice during anti-inflammatory therapy for traumatic brain injury.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    TLR
  • Recptor
    TLR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    872178-65-9
  • Formula Weight
    409.91
  • Molecular Formula
    C22H24ClN5O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(C(NCCN(C)C)=O)N1C=2C(C=3C1=CC=C(Cl)C3)=NC=4C(N2)=CC(C)=C(C)C4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • EPZ020411 2HCl

    EPZ020411 is an effective and specific small molecule PRMT6 inhibitor (IC50=10 nM).

  • BBIQ

    BBIQ is a powerful vaccine adjuvant that enhances innate immune responses and it is a imidazoquinoline compound and a potent and selectively toll-like receptor 7 (TLR7) agonist with an EC50 of 59.1 nM for human TLR7.

  • Isatoribine

    Isatoribine (ANA245;7-Thia-8-oxoguanosine;Immunosine) is a nucleoside analogue, selective agonist of TLR7 with significant antiviral effect and mmunoenhancing activity.